CHILDRENS IBUPROFEN ORAL SUSPENSION
Generic: IBUPROFEN
PAI HoldingsManufacturer
ORALRoute
IBUPROFENActive Substance
2024-11-08Original Approval
CHILDRENS IBUPROFEN ORAL SUSPENSION is FDA application ANDA214789, sponsored by PAI HOLDINGS PHARM. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
DRUG INEFFECTIVE
15,699 reports
2
PAIN
15,060 reports
3
FATIGUE
14,475 reports
4
NAUSEA
13,506 reports
5
HEADACHE
12,087 reports
6
ARTHRALGIA
10,919 reports
7
DYSPNOEA
10,527 reports
8
VOMITING
9,974 reports
9
DIARRHOEA
9,701 reports
10
RASH
9,031 reports